Certain Products Containing Pyraclostrobin and Components Thereof Notice of Institution, 11730-11731 [2022-04338]
Download as PDF
11730
Federal Register / Vol. 87, No. 41 / Wednesday, March 2, 2022 / Notices
C. Authority
Section 2 of the Paperwork Reduction
Act of 1995, 44 U.S.C. 3507.
Colette Pollard,
Department Reports Management Officer,
Office of the Chief Information Officer.
[FR Doc. 2022–04388 Filed 3–1–22; 8:45 am]
BILLING CODE 4210–67–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 731–TA–1557 (Final)]
Certain Mobile Access Equipment and
Subassemblies Thereof From China;
Supplemental Schedule for the Final
Phase of Antidumping Duty
Investigation
United States International
Trade Commission.
ACTION: Notice.
AGENCY:
DATES:
February 22, 2022.
lotter on DSK11XQN23PROD with NOTICES1
FOR FURTHER INFORMATION CONTACT:
Alejandro Orozco ((202) 205–3177),
Office of Investigations, U.S.
International Trade Commission, 500 E
Street SW, Washington, DC 20436.
Hearing-impaired persons can obtain
information on this matter by contacting
the Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server (https://
www.usitc.gov). The public record for
these investigations may be viewed on
the Commission’s electronic docket
(EDIS) at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION: Effective
July 30, 2021, the Commission
established a general schedule for the
conduct of the final phase of its
countervailing duty and antidumping
duty investigations on certain mobile
access equipment and subassemblies
thereof (‘‘mobile access equipment’’)
from China, following a preliminary
determination by the U.S. Department of
Commerce (‘‘Commerce’’) that imports
of subject mobile access equipment from
China were subsidized by the
government of China (86 FR 41013, July
30, 2021). Notice of the scheduling of
the final phase of the Commission’s
investigations and of a public hearing
held in connection therewith was given
by posting copies of the notice in the
Office of the Secretary, U.S.
International Trade Commission,
Washington, DC, and by publishing the
VerDate Sep<11>2014
17:34 Mar 01, 2022
Jkt 256001
notice in the Federal Register on August
12, 2021 (86 FR 44402). In light of the
restrictions on access to the Commission
building due to the COVID–19
pandemic, the Commission conducted
its hearing through written testimony
and video conference on October 12,
2021. All persons who requested the
opportunity were permitted to
participate.
Commerce issued a final affirmative
countervailing duty determination with
respect to mobile access equipment
from China (86 FR 57809, October 19,
2021). The Commission subsequently
issued its final determination that an
industry in the United States is
threatened with material injury by
reason of imports of mobile access
equipment from China provided for in
subheadings 8427.10.80, 8427.20.80,
8427.90.00, and 8431.20.00 of the
Harmonized Tariff Schedule of the
United States (‘‘HTSUS’’) that have been
found by Commerce to be subsidized by
the government of China (86 FR 70147,
December 9, 2021).
Commerce issued a final affirmative
antidumping duty determination with
respect to mobile access equipment
from China (87 FR 9576, February 22,
2022). Accordingly, the Commission
currently is issuing a supplemental
schedule for its antidumping duty
investigation on imports of mobile
access equipment from China.
This supplemental schedule is as
follows: The deadline for filing
supplemental party comments on
Commerce’s final antidumping duty
determination is March 7, 2022.
Supplemental party comments may
address only Commerce’s final
antidumping duty determination
regarding imports of mobile access
equipment from China. These
supplemental final comments may not
contain new factual information and
may not exceed five (5) pages in length.
The supplemental staff report in the
final phase of the current investigation
will be placed in the nonpublic record
on March 16, 2022, and a public version
will be issued thereafter.
For further information concerning
these investigations see the
Commission’s notices cited above and
the Commission’s Rules of Practice and
Procedure, part 201, subparts A and B
(19 CFR part 201), and part 207,
subparts A and C (19 CFR part 207).
Additional written submissions to the
Commission, including requests
pursuant to section 201.12 of the
Commission’s rules, shall not be
accepted unless good cause is shown for
accepting such submissions, or unless
the submission is pursuant to a specific
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
request by a Commissioner or
Commission staff.
In accordance with sections 201.16(c)
and 207.3 of the Commission’s rules,
each document filed by a party to the
investigations must be served on all
other parties to the investigations (as
identified by either the public or BPI
service list), and a certificate of service
must be timely filed. The Secretary will
not accept a document for filing without
a certificate of service.
Please note the Secretary’s Office will
accept only electronic filings during this
time. Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov). No in-person paperbased filings or paper copies of any
electronic filings will be accepted until
further notice.
Authority: These investigations are
being conducted under authority of title
VII of the Tariff Act of 1930; this notice
is published pursuant to section 207.21
of the Commission’s rules.
By order of the Commission.
Issued: February 25, 2022.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2022–04396 Filed 3–1–22; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1303]
Certain Products Containing
Pyraclostrobin and Components
Thereof Notice of Institution
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on
January 28, 2022, under section 337 of
the Tariff Act of 1930, as amended, on
behalf of BASF SE of Germany and
BASF Corporation, Florham Park, New
Jersey. A supplement to the Complaint
was filed on February 15, 2022. The
complaint, as supplemented, alleges
violations of section 337 based upon the
importation into the United States, the
sale for importation, and the sale within
the United States after importation of
certain products containing
pyraclostrobin and components thereof
by reason of infringement of certain
claims of U.S. Patent No. 7,816,392
(‘‘the ’392 patent’’). The complaint
further alleges that an industry in the
United States exists as required by the
applicable Federal Statute. The
SUMMARY:
E:\FR\FM\02MRN1.SGM
02MRN1
11731
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 41 / Wednesday, March 2, 2022 / Notices
complainant requests that the
Commission institute an investigation
and, after the investigation, issue a
limited exclusion order and cease and
desist orders.
ADDRESSES: The complaint, except for
any confidential information contained
therein, may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. For help
accessing EDIS, please email
EDIS3Help@usitc.gov. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at (202) 205–
2000. General information concerning
the Commission may also be obtained
by accessing its internet server at
https://www.usitc.gov.
FOR FURTHER INFORMATION CONTACT:
Jessica Mullan, Office of the Secretary,
Docket Services Division, U.S.
International Trade Commission,
telephone (202) 205–1802.
SUPPLEMENTARY INFORMATION:
Authority: The authority for
institution of this investigation is
contained in section 337 of the Tariff
Act of 1930, as amended, 19 U.S.C.
1337, and in section 210.10 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2021).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
February 24, 2022, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain products
identified in paragraph (2) by reason of
infringement of one or more of claims
1–17 of the ’392 patent, and whether an
industry in the United States exists as
required by subsection (a)(2) of section
337;
(2) Pursuant to section 210.10(b)(1) of
the Commission’s Rules of Practice and
Procedure, 19 CFR 210.10(b)(1), the
plain language description of the
accused products or category of accused
products, which defines the scope of the
investigation, is ‘‘products containing
crystalline modification IV of
pyraclostrobin and components
thereof’’;
(3) For the purpose of the
investigation so instituted, the following
VerDate Sep<11>2014
17:34 Mar 01, 2022
Jkt 256001
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are:
BASF SE, Carl-Bosch-Str. 38, 67056
Ludwigshafen, Germany
BASF Corporation, 100 Campus Drive,
Florham Park, New Jersey 07932
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Sharda Cropchem Ltd., Prime Business
Park, 2nd Floor, Mumbai,
Maharashtra, 400056, India
Sharda USA LLC, 34 E, Germantown
Pike #227, Norristown, PA 19401
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
The Office of Unfair Import
Investigations will not participate as a
party in this investigation.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), as
amended in 85 FR 15798 (March 19,
2020), such responses will be
considered by the Commission if
received not later than 20 days after the
date of service by the complainants of
the complaint and the notice of
investigation. Extensions of time for
submitting responses to the complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: February 24, 2022.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2022–04338 Filed 3–1–22; 8:45 am]
BILLING CODE 7020–02–P
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–967]
Bulk Manufacturer of Controlled
Substances Application: Sterling
Pharma USA, LLC
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Sterling Pharma USA, LLC
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 2, 2022. Such persons
may also file a written request for a
hearing on the application on or before
May 2, 2022.
DATES:
The DEA requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.’’
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on January 12, 2022,
Sterling Pharma USA, LLC, 1001
Sheldon Drive, Suite 101, Cary, North
Carolina 27513–2078, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Tetrahydrocannabinols .............
Drug
code
Schedule
7370
I
In reference to drug codes 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture this drug
exclusively from hemp extract for
distribution and sale to its customer. No
E:\FR\FM\02MRN1.SGM
02MRN1
Agencies
[Federal Register Volume 87, Number 41 (Wednesday, March 2, 2022)]
[Notices]
[Pages 11730-11731]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04338]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1303]
Certain Products Containing Pyraclostrobin and Components Thereof
Notice of Institution
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that a complaint was filed with the
U.S. International Trade Commission on January 28, 2022, under section
337 of the Tariff Act of 1930, as amended, on behalf of BASF SE of
Germany and BASF Corporation, Florham Park, New Jersey. A supplement to
the Complaint was filed on February 15, 2022. The complaint, as
supplemented, alleges violations of section 337 based upon the
importation into the United States, the sale for importation, and the
sale within the United States after importation of certain products
containing pyraclostrobin and components thereof by reason of
infringement of certain claims of U.S. Patent No. 7,816,392 (``the '392
patent''). The complaint further alleges that an industry in the United
States exists as required by the applicable Federal Statute. The
[[Page 11731]]
complainant requests that the Commission institute an investigation
and, after the investigation, issue a limited exclusion order and cease
and desist orders.
ADDRESSES: The complaint, except for any confidential information
contained therein, may be viewed on the Commission's electronic docket
(EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email
[email protected]. Hearing impaired individuals are advised that
information on this matter can be obtained by contacting the
Commission's TDD terminal on (202) 205-1810. Persons with mobility
impairments who will need special assistance in gaining access to the
Commission should contact the Office of the Secretary at (202) 205-
2000. General information concerning the Commission may also be
obtained by accessing its internet server at https://www.usitc.gov.
FOR FURTHER INFORMATION CONTACT: Jessica Mullan, Office of the
Secretary, Docket Services Division, U.S. International Trade
Commission, telephone (202) 205-1802.
SUPPLEMENTARY INFORMATION:
Authority: The authority for institution of this investigation is
contained in section 337 of the Tariff Act of 1930, as amended, 19
U.S.C. 1337, and in section 210.10 of the Commission's Rules of
Practice and Procedure, 19 CFR 210.10 (2021).
Scope of Investigation: Having considered the complaint, the U.S.
International Trade Commission, on February 24, 2022, ordered that--
(1) Pursuant to subsection (b) of section 337 of the Tariff Act of
1930, as amended, an investigation be instituted to determine whether
there is a violation of subsection (a)(1)(B) of section 337 in the
importation into the United States, the sale for importation, or the
sale within the United States after importation of certain products
identified in paragraph (2) by reason of infringement of one or more of
claims 1-17 of the '392 patent, and whether an industry in the United
States exists as required by subsection (a)(2) of section 337;
(2) Pursuant to section 210.10(b)(1) of the Commission's Rules of
Practice and Procedure, 19 CFR 210.10(b)(1), the plain language
description of the accused products or category of accused products,
which defines the scope of the investigation, is ``products containing
crystalline modification IV of pyraclostrobin and components thereof'';
(3) For the purpose of the investigation so instituted, the
following are hereby named as parties upon which this notice of
investigation shall be served:
(a) The complainants are:
BASF SE, Carl-Bosch-Str. 38, 67056 Ludwigshafen, Germany
BASF Corporation, 100 Campus Drive, Florham Park, New Jersey 07932
(b) The respondents are the following entities alleged to be in
violation of section 337, and are the parties upon which the complaint
is to be served:
Sharda Cropchem Ltd., Prime Business Park, 2nd Floor, Mumbai,
Maharashtra, 400056, India
Sharda USA LLC, 34 E, Germantown Pike #227, Norristown, PA 19401
(4) For the investigation so instituted, the Chief Administrative
Law Judge, U.S. International Trade Commission, shall designate the
presiding Administrative Law Judge.
The Office of Unfair Import Investigations will not participate as
a party in this investigation.
Responses to the complaint and the notice of investigation must be
submitted by the named respondents in accordance with section 210.13 of
the Commission's Rules of Practice and Procedure, 19 CFR 210.13.
Pursuant to 19 CFR 201.16(e) and 210.13(a), as amended in 85 FR 15798
(March 19, 2020), such responses will be considered by the Commission
if received not later than 20 days after the date of service by the
complainants of the complaint and the notice of investigation.
Extensions of time for submitting responses to the complaint and the
notice of investigation will not be granted unless good cause therefor
is shown.
Failure of a respondent to file a timely response to each
allegation in the complaint and in this notice may be deemed to
constitute a waiver of the right to appear and contest the allegations
of the complaint and this notice, and to authorize the administrative
law judge and the Commission, without further notice to the respondent,
to find the facts to be as alleged in the complaint and this notice and
to enter an initial determination and a final determination containing
such findings, and may result in the issuance of an exclusion order or
a cease and desist order or both directed against the respondent.
By order of the Commission.
Issued: February 24, 2022.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2022-04338 Filed 3-1-22; 8:45 am]
BILLING CODE 7020-02-P